Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taurolite plus plastic biliary stent for benign biliary stenosis
ChiCTR-IPR-16009691Phase 4Recruiting
- Sponsor
- Zhongnan Hospital of Wuhan University
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tauroursodeoxycholic acid in Benign Bile Duct Stricture (2 arms), sponsored by Zhongnan Hospital of Wuhan University. Primary endpoint: restenosis rate of plastic biliary stent. Started Oct 2016; status: recruiting.
02
Drugs
tauroursodeoxycholic acid
03
Conditions
Benign Bile Duct Stricture
Beyond the preview
Go deeper on ChiCTR-IPR-16009691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009691.